| Name | Company Name | Weight % | Market Value | Market Cap | Yearly Gain | Overall Rating | 
|---|---|---|---|---|---|---|
| ASML Holding NV | 5.54% | $717.78M | €351.20B | 43.73% | 78 Outperform | |
| Shell (UK) | 2.48% | $321.27M | £165.60B | 15.46% | 77 Outperform | |
| Allianz | 2.33% | $301.94M | €136.21B | 21.06% | 74 Outperform | |
| Roche Holding AG | 2.01% | $261.12M | CHF208.68B | 3.85% | 73 Outperform | |
| AstraZeneca | 1.95% | $253.24M | £194.71B | 12.08% | 75 Outperform | |
| Nestlé SA | 1.94% | $251.06M | CHF198.32B | 1.28% | 65 Neutral | |
| Novartis AG | 1.85% | $239.86M | CHF187.47B | 3.30% | 78 Outperform | |
| ABB Ltd | 1.84% | $238.94M | kr1.28T | 21.97% | 77 Outperform | |
| Zurich Insurance Group | 1.69% | $218.92M | CHF80.67B | 21.46% | 80 Outperform | |
| LVMH Moet Hennessy Louis Vuitton | 1.65% | $214.08M | €307.60B | 0.28% | 78 Outperform |